SA MEDICAL JOURNAL 497 Acrodermatitis Enteropathica - a Zinc
2
April 1978 SA MEDICAL JOURNAL 497 Acrodermatitis Enteropathica - a Zinc Deficiency State I. L. RUBIN, J. D. L. HANSEN, B. GOLDBERG, D. G. C. PRESBURY, T. A. KILROE-SMITH SUMMARY Successful therapy with zinc sulphate is reported in 3 children suffering from acrodermatitis enteropathica. S. Afr. med. J., 53, 497 (1978). Acrodermatitis enteropathica is a rare autosomal recessive disorder. rt is characterized by skin lesions, diarrhoea and alopecia. The skin lesions are typically vesicobullous and pustular during exacerbations and eczematoid or psoriasiform during quiescent phases of the disease. They are found at mucocutaneous junctions and on the ex- tremities. Onset of symptoms usually occurs within the first few months of life, frequently in association with the change in diet from breast milk to cow's milk. Management of this condition in the past has consisted of complete ab- stinence from cow's milk, the use of human milk where necessary and the daily administration of di-iodohydroxy- quinoline. Relapses on this form of treatment are frequent and complete control is often not possible. Furthermore, cases of optic atrophy caused by di-iodohydroxyquinoline have been consistently reported since 1966.' Recently Moynahan and Barne,s' described a girl with acrodermatitis enteropathica who failed to respond to any of the known forms of therapy. The trace elements in the serum were studied and she was found to be de- ficient in zinc.' Oral zinc supplementation resulted in dramatic improvement of the clinical condition, with tolerance 'of a normal diet. Subsequently Moynahan re- ported the successful treatment of 9 further patients with oral zinc sulphate.' This finding has been confirmed by others!,5 We should like to report the successful management of 3 further cases. CASE REPORTS Case 1 A I-month-old boy presented with an extensive eruption Department of Paediatrics, University of the Witwatersrand and Transvaal Memorial Hospital for Children, Johannes- burg 1. L. RUBIN, M.B. B.CH., B.SC. J. D. L. HANSEN, M.D., F.R.C.P., D.C.H. Department of Dermatology, University of the Witwatersrand, Johannesburg B. GOLDBERG, M.B. B.CH. D. G. C. PRESBURY, M.B. B.S., M.n.c.p. National Research Institute for Occupational Diseases of the South African Medical Research Council, Johannesburg T. A. KlLROE-SMITH, PH.D. Date received: 2 September 1977. Reprint requests to: Professor J. D. L. Hansen, Department of Paediatrics. Transvaal Memorial Hospital for Children, Private Bag X39, Milner Park, Johannesburg, 2000 RSA. around the mouth and anus. This occurred after his mother stopped breast feeding and began feeding him on cow's milk. The cow's milk was stopped and breast feeding restarted, with a resultant improvement in his condition. He remained well while on breast milk, but at 6 months of age he was again weaned on to cow's milk. There was exacerbation of his sympt.:>ms and management with di-iodohydroxyquinoline and strict dietary control became necessary. He remained reasonably well on this regimen until he was 4 years old. At this stage, for no obvious reason, he developed severe diarrhoea, extensive skin lesions and alopecia. It took 9 months to regain control over his condition. He remained well for only 9 months. He then, at the age of 6 years, developed photophobia. This was thought to be caused by the di-iodohydroxy- quinoline, which was discontinued. He relapsed imme- diately with severe manifestations of the disease and was admitted to hospital. A full blood count, urea and electro- lytes, serum proteins and immunoglobulins were all normal. Serum zinc was low: 360 fLg/1 (normal 1 200 ± 190 p.g/I). He was given oral zinc sulphate (50 mg 3 times a day) and there was a dramatic overall improvement of his condition within a week. The serum zinc level 2 weeks later was 2240 ,fLg/1. His condition has remained well controlled and he has been on a normal diet for 10 months. Case 2 The 13-year-old sister of patient 1 had presented with similar symptoms and had had similar problems in child- hood. At the time of her brother's admission to hospital she had been fairly well controlled on di-iodohydroxy- quinoline with dietary restriction. She did, however, have seborrhoeic dermatitis on her scalp, eczematoid lesions on her limbs and some dystrophy of her nails. The serum zinc level was 670 fLg/l. Di-iodohydroxyquinoline was stopped and she was observed for 2 weeks on a normal diet. During this time her skin lesions became progressively more marked. Treatment with zinc sulphate (50 mg 3 times a day) was then started. Within 2 weeks her skin lesions had cleared completely. Case 3 This boy presented at 2t years of age with eczematoid lesions at mucocutaneous junctions, bullous and pustular lesions on the extremities (Figs 1 - 3), and alopecia. He had never had diarrhoea. He had a history of recurrent severe napkin dermatitis from 1 week of age and al- though he had had no definitive treatment, had enjoyed spontaneous remissions of several months' duration. The serum zinc level was 900 fLg / I. As with the other patients, the response to zinc sulphate (25 mg 3 times a day) was dramatic and the lesions cleared within a week. The serum zinc level was then 840 fLg/1.
Transcript of SA MEDICAL JOURNAL 497 Acrodermatitis Enteropathica - a Zinc
April 1978 SA MEDICAL JOURNAL 497
Acrodermatitis Enteropathica - a Zinc Deficiency State
I. L. RUBIN, J. D. L. HANSEN, B. GOLDBERG, D. G. C. PRESBURY,T. A. KILROE-SMITH
SUMMARYSuccessful therapy with zinc sulphate is reported in 3children suffering from acrodermatitis enteropathica.
S. Afr. med. J., 53, 497 (1978).
Acrodermatitis enteropathica is a rare autosomal recessivedisorder. rt is characterized by skin lesions, diarrhoeaand alopecia. The skin lesions are typically vesicobullousand pustular during exacerbations and eczematoid orpsoriasiform during quiescent phases of the disease. Theyare found at mucocutaneous junctions and on the extremities.
Onset of symptoms usually occurs within the first fewmonths of life, frequently in association with the changein diet from breast milk to cow's milk. Management ofthis condition in the past has consisted of complete abstinence from cow's milk, the use of human milk wherenecessary and the daily administration of di-iodohydroxyquinoline. Relapses on this form of treatment are frequentand complete control is often not possible. Furthermore,cases of optic atrophy caused by di-iodohydroxyquinolinehave been consistently reported since 1966.'
Recently Moynahan and Barne,s' described a girl withacrodermatitis enteropathica who failed to respond toany of the known forms of therapy. The trace elementsin the serum were studied and she was found to be deficient in zinc.' Oral zinc supplementation resulted indramatic improvement of the clinical condition, withtolerance 'of a normal diet. Subsequently Moynahan reported the successful treatment of 9 further patientswith oral zinc sulphate.' This finding has been confirmedby others!,5 We should like to report the successfulmanagement of 3 further cases.
CASE REPORTSCase 1
A I-month-old boy presented with an extensive eruption
Department of Paediatrics, University of the Witwatersrandand Transvaal Memorial Hospital for Children, Johannesburg
1. L. RUBIN, M.B. B.CH., B.SC.
J. D. L. HANSEN, M.D., F.R.C.P., D.C.H.
Department of Dermatology, University of the Witwatersrand,Johannesburg
B. GOLDBERG, M.B. B.CH.D. G. C. PRESBURY, M.B. B.S., M.n.c.p.
National Research Institute for Occupational Diseases of theSouth African Medical Research Council, Johannesburg
T. A. KlLROE-SMITH, PH.D.
Date received: 2 September 1977.Reprint requests to: Professor J. D. L. Hansen, Department of Paediatrics.Transvaal Memorial Hospital for Children, Private Bag X39, MilnerPark, Johannesburg, 2000 RSA.
around the mouth and anus. This occurred after his motherstopped breast feeding and began feeding him on cow'smilk. The cow's milk was stopped and breast feedingrestarted, with a resultant improvement in his condition.He remained well while on breast milk, but at 6 monthsof age he was again weaned on to cow's milk. There wasexacerbation of his sympt.:>ms and management withdi-iodohydroxyquinoline and strict dietary control becamenecessary. He remained reasonably well on this regimenuntil he was 4 years old. At this stage, for no obviousreason, he developed severe diarrhoea, extensive skinlesions and alopecia. It took 9 months to regain controlover his condition. He remained well for only 9 months.He then, at the age of 6 years, developed photophobia.This was thought to be caused by the di-iodohydroxyquinoline, which was discontinued. He relapsed immediately with severe manifestations of the disease and wasadmitted to hospital. A full blood count, urea and electrolytes, serum proteins and immunoglobulins were all normal.Serum zinc was low: 360 fLg/1 (normal 1 200 ± 190 p.g/I).He was given oral zinc sulphate (50 mg 3 times a day)and there was a dramatic overall improvement of hiscondition within a week. The serum zinc level 2 weekslater was 2240 ,fLg/1. His condition has remained wellcontrolled and he has been on a normal diet for 10 months.
Case 2The 13-year-old sister of patient 1 had presented with
similar symptoms and had had similar problems in childhood. At the time of her brother's admission to hospitalshe had been fairly well controlled on di-iodohydroxyquinoline with dietary restriction. She did, however, haveseborrhoeic dermatitis on her scalp, eczematoid lesions onher limbs and some dystrophy of her nails. The serumzinc level was 670 fLg/l. Di-iodohydroxyquinoline wasstopped and she was observed for 2 weeks on a normaldiet. During this time her skin lesions became progressivelymore marked. Treatment with zinc sulphate (50 mg 3 timesa day) was then started. Within 2 weeks her skin lesionshad cleared completely.
Case 3This boy presented at 2t years of age with eczematoid
lesions at mucocutaneous junctions, bullous and pustularlesions on the extremities (Figs 1 - 3), and alopecia. Hehad never had diarrhoea. He had a history of recurrentsevere napkin dermatitis from 1 week of age and although he had had no definitive treatment, had enjoyedspontaneous remissions of several months' duration. Theserum zinc level was 900 fLg / I. As with the other patients,the response to zinc sulphate (25 mg 3 times a day)was dramatic and the lesions cleared within a week. Theserum zinc level was then 840 fLg/1.
498 SA MEDIESE TYDSKRIF 1 April 1978
Fig. 1. Case 3. Eczematoid lesions round the mouth andnose.
Fig. 2. Eczematoid lesions on the buttocks and thighs.
Fig. 3. Pustular lesions and nail dystrophy on the foot.
DISCUSSION
Zinc is an essential element whose deficiency retardsgrowth and maturation in animals and plants. Numerouszinc metallo-enzymes are concerned in the regulation ofcellular growth, and zinc ions are needed for efficientnucleic acid and protein synthesis. Zinc deficiency inanimals produces abnormalities of skin and appendagessuch as hair, horns, nails and hooves.
Although low levels of zinc are described in associationwith conditions such as kwashiorkor; tissue injuri andwith phytate-rich diets,' no true zinc deficiency state hasbeen described in man. Acrodermatitis enteropathica seemsto fulfil the criteria in that low levels of zinc are foundand administration of zinc completely reverses the condition. The addition of very small amounts of rinc to thediet will reverse the clinical picture even if the serumzinc level is not appreciably altered' (as is demonstratedin case 3).
The nature of the defect in acrodermatitis enteropathicais at present unknown, despite the thorough investigationof recently reported cases.'O
•U The lack of an appropriate
gastro-intestinal transport factor, which is corrected byadditional oral zinc, is one of several p·ossibilities." It isstill not understood why breast milk is beneficial whereascow's milk, which contains the same amount of zinc, isdefinitely harmful. Nor is the therapeutic action of diiodohydroxyquinoline understood. The therapeutic role ofzinc in acrodermatitis enteropathica has opened horizonsfor the further study of zinc metabolism in animals andman.
We know that zinc metabolism is disturbed in acro~
dermatitis enteropathica as well as in other conditions."""However, the clinical and biochemical association in theseconditions is by no means constant. This was well de,monstrated in the patients described here. Whereas patientsI and 2 presented with florid classic acrodermatitis enteropathica, with regard to both clinical features and lowserum rinc levels, patient 3 had a purely dermatologicalproblem. In addition, he had spontaneous remissions andon successful therapy serum zinc levels had in fact remained relatively unchanged - just below the lower limitof normal.
The possible role of zinc in the management of persistent dermatological and even gastro-intestinal problemsremains to be investigated. At present we can only stronglyrecommend the use of oral zinc sulphate for the management of acrodermatitis enteropathica, and it seems thatcontinuous maintenance therapy will be necessary.
REFERENCES
1. Berggren, L. and Hansson, O. (1966): Lancet, 1, 52.2. Moynahan, E. J. and Barnes, P. M. (1973): Ibid., 1, 676.3. Moynahan, E. J. (1974): Ibid., 2, 399.4. Ponnoy, B. and Molokhia, M. (1974): Ibid., 2, 663.5. Robenson. A. F. and Sotos, J. (1975): Paediatrics, 55, 738.6. Hansen. J. D. Land Lehman, B. H. (1969): S. Afr. med. J.,
43. 1248.7. Fell, G. S., Cuthbertson, D. P., Momson, C. et al. (1973): Lancet,
1, 280.8. Rheingold, J. G., Lahingarzaden, A., Nasr, K. et al. (1973): Ibid.,
I, 283.9. Nelder. K. H. and Hambridge, K. M. (1975): New Eng!. J. Med.,
292, 879.10. Michaelsson, G. (1974): Acta derm.-venereol. (Stockh.), 54, 377.11. Nelder, K. H., Hagler, L., Wise, W. R. et aJ. (1974): Arch. Derm.,
110, 711.12. Henkin, R. I. an!! Aamodt, R. L. (1975): Lancet, I, 1379.
